StockData
Immix Biopharma, Inc. logo

Immix Biopharma, Inc. (IMMX) stock

IMMXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$7.20−0.28 (-3.74%)

Close on Nov 17, 2026Market cap $515.08MP/E –Yield –

Immix Biopharma market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Immix Biopharma's market cap was $619.50M on Nov 11, 2026, against $140.40M a year earlier. Over the last 5 years it ranged from $12.02M to $1.00B, with a median of $55.70M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$619.50M+258.6%
2025Dec 31, 2025$172.78M+185.8%
2024Dec 31, 2024$60.46M-55.4%
2023Dec 29, 2023$135.69M+325.5%
2022Dec 30, 2022$31.89M+165.4%
2021Dec 31, 2021$12.02M–

More Immix Biopharma figures

See a number that looks wrong?